CD8A and neoplasm: It has been speculated that, after allo-SCT or ASCT when the tumor load is low, lymphocyte infusion will help restore immune capacity through the expansion of low levels of Treg and CD8 + cells, and vaccination at this time can trigger tumor antigen-specific immunity [79].